Registration Options

Activity Dates: 09/09/2024 - 12/31/2025

Session Time

Date: Monday, 09/09/2024

Time: 4:00 PM

Target Audience

We invite you to participate in this online course if you are a pharmacist, nurse, or other health care professional interested in administering and/or learning more about psychotropic long-acting injectables for patients living with serious mental illness or substance use disorders.

Session Summary

Live Peer-to-Peer Virtual Networking Session on September 9, 2024 from 4:00-5:00 CST

This module highlights evidence to support earlier use of LAIs in the treatment of patients with schizophrenia or bipolar disorder, how pharmacists can assist with LAI administration and continuity during transitions of care, strategies that address barriers to maintaining the LAI injection schedule during transitions of care, and how to involve patients and family members in shared decision making to create treatment goals and improve adherence. This activity includes a 0.5-hour pre-recorded presentation and a 1-hour live, peer-to-peer virtual networking session.

This is one of six modules in the Advanced Track Psychotropic Long-Acting Injectable Program. Complete your complimentary registration now to access this module and 5 other ACPE approved modules.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Discuss evidence to support the earlier use of LAIs in the treatment of patients with schizophrenia or bipolar disorder. 
  2. Describe how pharmacists can assist with LAI administration and continuity during transitions of care. 
  3. Identify strategies that address barriers to maintaining the LAI injection schedule during transitions of care. 
  4. Explain how to involve patients and family members in shared decision making to create treatment goals and improve adherence.

Continuing Education Credit and Disclosures

Activity Dates: 09/09/2024 - 12/31/2025
ACPE Contact Hours: 1
ACPE Number: 0284-0000-24-051-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

This activity is supported by educational grants from Indivior, Inc., Janssen Scientific Affairs, LLC, and Otsuka America Pharmaceutical, Inc.